BRIEF-Innovative Industrial Properties Q2 Revenue USD 62.9 Million Vs. IBES Estimate USD 63.9 Million

Reuters
08/07
Innovative Industrial Properties <a href="https://laohu8.com/S/QTWO">Q2</a> revenue misses expectations

Overview

  • Innovative Industrial Properties Q2 revenue misses analyst expectations, down 21% yr/yr

  • Net income for Q2 declines significantly compared to last year

  • Co repurchased $20 mln of common stock, maintaining liquidity over $190 mln

Result Drivers

  • TENANT DEFAULTS - Tenant defaults, including PharmaCann and others, led to a $15.8 mln revenue decline

  • PROPERTY SALES - Revenue decreased due to properties vacated or sold, impacting income by $1.3 mln

  • NEW LEASES - Revenue partially offset by $1.5 mln increase from new leases on existing properties

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Miss

$62.90 mln

$63.90 mln (5 Analysts)

Q2 Net Income

$25.10 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and 2 "sell" or "strong sell"

  • The average consensus recommendation for the commercial reits peer group is "buy."

  • Wall Street's median 12-month price target for Innovative Industrial Properties Inc is $53.00, about 1.3% above its August 5 closing price of $52.29

  • The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release: ID:nBw4xjlk9a

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10